Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term Use of Alogliptin/Pioglitazone Combination Tablets in Patients With Type 2 Diabetes Mellitus

NCT01990300 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT01990300
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01990300 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term Use of Alogliptin/Pioglitazone Combination Tablets in Patients With Type 2 Diabetes Mellitus
Lead sponsor
Takeda
Phase
Observational
Overall status
Completed
Start date
November 28, 2011
Completion date
March 31, 2015
Enrollment
3,281 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus